专家：乳腺癌筛查不是“一筛了之” 精准诊疗需要贯穿全局

Core Insights - The biggest challenge in breast cancer treatment is the imbalance in medical knowledge dissemination, information asymmetry between doctors and patients, and unequal access to drug resources, leading to patients spending money without effective treatment [1] Group 1: Breast Cancer Statistics - In 2022, there were 357,200 new cases of breast cancer in China, making it the second most common cancer among women after lung cancer, accounting for 15.6% of new cancer cases [2] Group 2: Screening Challenges - Despite ongoing screening efforts for "two cancers," many women still present with late-stage breast cancer upon diagnosis [3] - There are instances where patients delay seeking medical help until the disease has progressed significantly, often due to missed screenings or notifications [4] Group 3: Screening Recommendations - Regular and continuous screening is essential for high-risk groups to avoid missing the optimal treatment window. Screening plans should be tailored based on age and risk factors, with recommendations for more frequent screenings for those with family histories or atypical hyperplasia [4] Group 4: Treatment Inefficiencies - There is a discrepancy in the use of early treatment options that are covered by insurance, with patients often receiving more expensive late-stage treatments due to information asymmetry and unequal medical resources [5] - Emphasizing precision diagnosis and treatment is crucial, as different stages of cancer require different treatment approaches [5] Group 5: Cost and Accessibility of Testing - Many patients face high costs for testing, which necessitates the standardization of testing procedures and reasonable pricing to improve patient acceptance [6] - The importance of public education and outreach in breast cancer awareness and screening is highlighted, with calls for experts to engage more with communities and grassroots efforts [6]